Centene Corporation

CNC Healthcare Healthcare Plans

Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

68.86 1.84 +2.75%
Market cap
$33.1B
P/E
0.0×
Fwd P/E
24.8×
Dividend yield
—
F-score
5/9
Altman Z
2.64
Beneish M
−3.07
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
18.06 21.38 24.32 19.71 19.24 35.67 38.34 15.58 9.66 0.00
Piotroski F-Score
4 4 5 5 5 5 7 8 5 5
Altman Z-Score
2.71 3.23 2.95 2.90 2.41 2.43 2.67 2.60 2.76 2.64
P/S ratio
0.23 0.37 0.37 0.35 0.31 0.38 0.32 0.27 0.19 0.10
P/FCF ratio
6.02 16.58 40.25 34.52 7.39 14.58 8.72 5.75 0.00 4.70
Altman Z″-Score (non-manufacturers)
1.08 1.07 1.29 2.34 1.43 1.27 1.14 1.47 1.66 0.39
Beneish M-Score
(1.70) (2.47) (2.18) (2.29) (2.16) (2.31) (2.79) (2.70) (1.99) (3.07)
P/Operating CF
5.85 39.31 (35.49) (39.93) 11.49 71.15 (29.10) 192.37 (53.85) 46.43
P/B ratio
1.57 2.58 2.04 2.05 1.32 1.78 1.90 1.61 1.19 1.01
Price to Tangible BV
0.00 24.67 12.79 6.96 0.00 0.00 0.00 18.32 8.95 4.35
EV/Sales
0.23 0.37 0.38 0.36 0.35 0.41 0.34 0.26 0.21 0.09
EV/EBITDA
6.18 11.40 11.84 11.03 8.91 16.74 18.01 9.45 7.58 0.00
EV/Operating CF
5.15 11.95 18.74 18.03 7.03 12.42 7.90 4.96 217.26 3.41
EV/FCF
6.17 16.67 41.36 35.51 8.34 15.84 9.41 5.50 (68.28) 4.02
Quick Ratio
0.89 0.86 0.94 1.49 1.02 1.04 0.97 0.96 1.06 1.05
Current Ratio
0.97 0.93 1.00 1.57 1.08 1.11 1.06 1.11 1.11 1.10
Net Debt/EBITDA
0.14 0.06 0.32 0.31 1.01 1.34 1.32 (0.43) 0.42 0.46
Debt/Assets
23.05% 21.50% 21.64% 33.48% 24.42% 24.04% 23.44% 21.06% 22.48% 22.67%
Debt/Equity
0.79 0.68 0.61 1.08 0.65 0.70 0.75 0.69 0.70 0.87
Asset Turnover
2.95 2.30 2.28 2.08 2.03 1.71 1.86 1.91 1.95 2.45
Operating CF/Net income
3.29 1.80 1.37 1.12 3.04 3.12 5.21 2.98 0.05 (0.76)
Capex/Depreciation
(1.10) (1.17) (1.36) (1.14) (0.69) (0.68) (0.70) (0.62) (0.52) (0.60)
Interest Coverage
5.82 4.70 4.25 4.32 4.23 2.68 1.98 4.04 4.52 (11.24)
ROE
13.92% 12.96% 10.07% 11.16% 9.38% 5.10% 4.70% 10.78% 12.61% (28.69%)
ROA
4.08% 3.94% 3.41% 3.67% 3.30% 1.83% 1.55% 3.35% 3.96% (8.38%)
ROIC
12.88% 10.77% 7.83% 8.31% 6.36% 3.58% 2.96% 7.59% 7.00% (27.84%)
Return on Tangible Assets
104.27% 174.32% 51.93% 13.89% 39.46% 22.00% 29.35% 44.59% 56.93% (116.86%)
Average Days of Receivables
28.90 25.75 31.27 30.55 31.85 35.46 33.51 36.81 44.12 33.93
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
9.05% 9.19% 10.05% 8.75% 8.44% 7.62% 8.02% 8.16% 7.60% 6.63%
Intangible Assets out of Total Assets
0.31 0.28 0.30 0.22 0.39 0.35 0.33 0.28 0.28 0.20
Share Based Compensation of Revenue
0.36% 0.28% 0.24% 0.24% 0.25% 0.16% 0.16% 0.14% 0.13% 0.10%
Graham Net Nets
(0.64) (0.36) (0.35) (0.31) (0.57) (0.48) (0.49) (0.43) (0.57) (0.81)
Graham Number
25.94 32.78 38.79 46.88 56.43 49.01 44.36 72.77 84.64 0.00
Earnings Yield
5.54% 4.68% 4.11% 5.07% 5.20% 2.80% 2.61% 6.42% 10.35% (33.07%)
Free Cash Flow Yield
16.60% 6.03% 2.48% 2.90% 13.53% 6.86% 11.46% 17.38% (1.55%) 21.29%
Revenue per Share
127.24 140.30 154.05 180.51 194.69 216.15 251.30 283.44 312.52 394.99
Operating CF per Share
5.80 4.32 3.16 3.59 9.64 7.21 10.89 14.82 0.30 10.32
Capex per Share
(0.96) (1.22) (1.73) (1.77) (1.52) (1.56) (1.75) (1.47) (1.23) (1.56)
Free Cash Flow per Share
4.84 3.09 1.43 1.82 8.12 5.65 9.14 13.35 (0.94) 8.76
Cash per Share
13.90 13.35 15.54 31.41 21.69 25.15 25.03 36.17 31.98 41.21
Shareholders Equity per Share
18.52 19.90 28.22 30.62 45.35 46.22 42.04 47.74 50.79 40.63
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
18.52 19.90 28.22 30.62 45.35 46.22 42.04 47.74 50.79 40.63
Free Cash Flow
1,545.00 1,067.00 559.00 753.00 4,634.00 3,295.00 5,257.00 7,254.00 (490.00) 4,321.00
Working Capital
(258.00) (629.00) 27.00 7,391.00 1,808.00 2,732.00 1,664.00 4,040.00 3,738.00 3,674.00
Capital Expenditures
(306.00) (422.00) (675.00) (730.00) (869.00) (910.00) (1,004.00) (799.00) (644.00) (767.00)
Net Current Asset Value
(5,923.00) (6,288.00) (7,890.00) (8,012.00) (19,441.00) (22,938.00) (22,561.00) (17,948.00) (17,946.00) (16,344.00)
EV/EBIT
7.54 14.83 15.86 15.01 12.54 29.26 37.55 13.62 10.54 0.00
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00
Price to Operating Income
7.37 14.75 15.43 14.60 11.12 26.92 34.80 14.25 9.96 0.00
Other line items
Depreciation/Fixed assets
0.35 0.33 0.29 0.30 0.45 0.39 0.59 0.64 0.60 0.63
Cash ROIC
10.30% 6.60% 2.35% 1.91% 8.42% 5.45% 9.29% 11.44% (0.79%) 7.48%
Accounts Receivable Turnover
18.07 14.60 14.04 13.10 13.94 11.49 11.33 10.69 9.25 10.30
Accounts Payable Turnover
14.80 10.74 12.58 16.02 17.07 14.37 14.20 10.54 9.88 13.43
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
39.17 35.70 28.60 23.10 26.91 27.73 27.18 43.85 32.88 27.79
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
2,247.00 3,314.00 4,281.50 5,698.50 7,971.50 10,967.00 12,755.00 14,402.00 17,622.50 18,909.00
Average Payables
2,369.50 3,964.00 4,108.00 4,107.50 5,616.50 7,781.00 9,009.00 12,972.50 14,797.00 13,474.00
Average Assets
13,768.00 21,026.00 26,378.00 35,947.50 54,856.50 73,547.00 77,622.50 80,755.50 83,543.00 79,596.00
Average Common Equity
4,038.50 6,386.50 8,938.50 11,836.00 19,272.00 26,412.50 25,560.50 25,059.00 26,218.50 23,266.50

Fold the line items

Columns are period end dates